Arkolith/Insider Trading/HILS/Form 4

Milby Randy

Chief Executive Officer, DirectorHillstream BioPharma Inc. (HILS) · full profile →Form 4 · filed Jan 20, 2022
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
28
14 non-derivative · 14 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jan 14, 2022Conversion(C)17K$3.20$53K2.2M
Jan 14, 2022Conversion(C)182K$3.20$584K2.1M
Jan 14, 2022Conversion(C)12K$3.20$37K2.0M
Jan 14, 2022Conversion(C)10K$3.20$32K1.9M
Jan 14, 2022Conversion(C)17K$3.20$54K1.9M
Jan 14, 2022Conversion(C)13K$3.20$43K1.9M
Jan 14, 2022Conversion(C)13K$3.20$43K1.9M
Jan 14, 2022Conversion(C)14K$3.20$43K1.9M
Jan 14, 2022Conversion(C)19K$3.20$60K1.9M
Jan 14, 2022Conversion(C)10K$3.20$33K1.8M
Jan 14, 2022Conversion(C)678$3.20$2K1.8M
Jan 14, 2022Conversion(C)31K$3.20$98K1.8M
Jan 14, 2022Conversion(C)27K$3.20$88K1.8M
Jan 14, 2022Conversion(C)19K$3.20$60K1.9M

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jan 14, 2022Conversion(C)0—$00
Jan 14, 2022Conversion(C)0—$00
Jan 14, 2022Conversion(C)0—$00
Jan 14, 2022Conversion(C)0—$00
Jan 14, 2022Conversion(C)0—$00
Jan 14, 2022Conversion(C)0—$00
Jan 14, 2022Conversion(C)0—$00
Jan 14, 2022Conversion(C)0—$00
Jan 14, 2022Conversion(C)0—$00
Jan 14, 2022Conversion(C)0—$00
Jan 14, 2022Conversion(C)0—$00
Jan 14, 2022Conversion(C)0—$00
Jan 14, 2022Conversion(C)0—$00
Jan 14, 2022Conversion(C)0—$00

Transaction Codes

C
Conversion of a derivative

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001493152-22-001674) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML